D J Sargent

发表

Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.

J P Pignon, S Michiels, B Baujat, 2005, Journal of clinical epidemiology.

Validation of novel imaging methodologies for use as cancer clinical trial end-points.

C Gatsonis, D J Sargent, L. Schwartz, 2009, European journal of cancer.

A Flexible Approach to Time-varying Coefficients in the Cox Regression Setting

D J Sargent, D. Sargent, 1997, Lifetime data analysis.

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

M E Hammond, C C Compton, D J Sargent, 2000, Archives of pathology & laboratory medicine.

Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report.

D J Sargent, D. Sargent, H. Nelson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.

D J Sargent, L A Renfro, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group.

D J Sargent, J. Helterbrand, D. Sargent, 2011, European journal of cancer.

Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07, and C89803.

M Buyse, D J Sargent, D. Sargent, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multi‐state models for colon cancer recurrence and death with a cured fraction

D J Sargent, D. Sargent, A. Conlon, 2014, Statistics in medicine.

The radial distance of extraprostatic extension of prostate carcinoma

D W Hillman, D J Sargent, D. Bostwick, 1999, Cancer.

Robust Bayesian approaches for clinical trial monitoring.

B P Carlin, D J Sargent, B. Carlin, 1996, Statistics in medicine.

A general framework for random effects survival analysis in the Cox proportional hazards setting.

D J Sargent, D. Sargent, 1998, Biometrics.